

Acurx Pharmaceuticals (NASDAQ:ACXP) shares down on Friday after reporting net loss for Q4 2025, but with positive cash and $1.5M raised.
You can purchase shares of Acurx Pharmaceuticals (NASDAQ:ACXP) through any online brokerage.
Other companies in Acurx Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Acurx Pharmaceuticals has a consensus price target of $143.67.
The stock price for Acurx Pharmaceuticals (NASDAQ: ACXP) is $1.11 last updated November 10, 2026 at 8:35 AM EST.
There are no upcoming dividends for Acurx Pharmaceuticals.
Acurx Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Acurx Pharmaceuticals.
Acurx Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive...